The ICD10 code for the diagnosis "Benign prostatic hyperplasia with lower urinary tract symptoms" is "N40.1". N40.1 is a VALID/BILLABLE ICD10 code, i.e it is valid for submission for HIPAA-covered transactions. N40.1 is a billable /specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
ICD-10 Code: N40.1 – Benign Prostatic Hyperplasia with Lower Urinary Tract Symptoms. ICD-9 Code Transition: 600.01 Code N40.1 is the diagnosis code used for Benign Prostatic Hyperplasia with Lower Urinary Tract Symptoms, also called benign enlargement of the prostate (BEP or BPE). It is a benign (noncancerous) increase in size of the prostate.
They must be used in conjunction with an underlying condition code and they must be listed following the underlying condition. code for associated symptoms, when specified: incomplete bladder emptying ( ICD-10-CM Diagnosis Code R39.14 nocturia ( ICD-10-CM Diagnosis Code R35.1 straining on urination ( ICD-10-CM Diagnosis Code R39.16
R39.14 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2018/2019 edition of ICD-10-CM R39.14 became effective on October 1, 2018. This is the American ICD-10-CM version of R39.14 - other international versions of ICD-10 R39.14 may differ.
ICD-10 code R39. 14 for Feeling of incomplete bladder emptying is a medical classification as listed by WHO under the range - Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified .
Benign prostatic hyperplasia without lower urinary tract symptoms. N40. 0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
ICD-10 code: N13. 8 Other obstructive and reflux uropathy.
Benign prostatic hyperplasia with lower urinary tract symptoms. N40. 1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM N40.
ICD-10 code R33. 9 for Retention of urine, unspecified is a medical classification as listed by WHO under the range - Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified .
Codes for observation are reported as the primary code when used with the exception of code Z05 which may be first listed or as an additional code sequenced after a code from category Z38. Aftercare codes are used to report the confirmed care the patient receives after the acute phase of treatment.
Neoplasm of unspecified behavior of bladder D49. 4 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM D49. 4 became effective on October 1, 2021.
ICD-10 code N32. 0 for Bladder-neck obstruction is a medical classification as listed by WHO under the range - Diseases of the genitourinary system .
596.54 - Neurogenic bladder NOS. ICD-10-CM.
9: Fever, unspecified.
BOO and/or changes in smooth muscle tone and resistance that can accompany BPH often result in lower urinary tract symptoms (LUTS). 1. LUTS are storage disturbances, such as daytime urinary urgency and nocturia, and/or voiding disturbances, such as urinary hesitancy, weak stream, straining, and prolonged voiding. 2.
R39. 9 - Unspecified symptoms and signs involving the genitourinary system | ICD-10-CM.
Code N40.1 is the diagnosis code used for Benign Prostatic Hyperplasia with Lower Urinary Tract Symptoms, also called benign enlargement of the prostate (BEP or BPE). It is a benign (noncancerous) increase in size of the prostate.
ICD-10 is required for use by physicians and healthcare providers under the Health Insurance Portability & Accountability Act (HIPAA) and will replace all ICD-9 code sets.